![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Teva Gets EU Nod for Neulasta ‘Biobetter’
Teva Gets EU Nod for Neulasta ‘Biobetter’
August 12, 2013
Teva’s own brand drug Lonquex has won EU approval and will compete with Amgen’s Neulasta in the stimulation of white blood cells to treat chemotherapy-induced neutropenia and febrile neutropenia.
Pharma Times
Pharma Times
Upcoming Events
-
21Oct